Stephens Consulting, LLC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 78 filers reported holding KEMPHARM INC in Q3 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$9,640
-5.5%
2,0000.0%0.00%0.0%
Q2 2023$10,200
-7.3%
2,0000.0%0.00%
-42.9%
Q1 2023$11,000
+19.8%
2,0000.0%0.01%
+16.7%
Q4 2022$9,180
-26.4%
2,0000.0%0.01%
-45.5%
Q3 2022$12,480
+39.9%
2,0000.0%0.01%
+57.1%
Q2 2022$8,920
-11.3%
2,0000.0%0.01%
-12.5%
Q1 2022$10,060
-48.1%
2,000
-10.1%
0.01%
-50.0%
Q4 2021$19,3802,2250.02%
Other shareholders
KEMPHARM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders